2 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 1 | 1 | Recruiting 1 |
Follow Local Recurrence: new trials by email Literature Review of Local Recurrence trials Research Report on Local Recurrence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC MRG003, Tislelizumab, Capecitabine - Nasopharyngeal Carcinoma, Local Recurrence | Phase 2 | Recruiting | Fujian Cancer Hospital | 25 | 2026-06-16 | 2026-10-19 |
| B7-H3 NIR Imaging for Osteosarcoma Surgery a targeted probe B7H3-IRDye800CW - Osteosarcoma, Resection Margins | Phase 1 / Phase 2 | Recruiting | Peking University People's Hospital | 32 | 2024-01-01 | 2025-01-16 |
Margins of Excision (1) · Nasopharyngeal Carcinoma (1) · Osteosarcoma (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Carcinoma (1) · Head and Neck Neoplasms (1) · Morphological and Microscopic Findings (1) · Nasopharyngeal Diseases (1) · Nasopharyngeal Neoplasms (1) · Neoplasms by Site (1) · Neoplasms, Bone Tissue (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Glandular and Epithelial (1) · Otorhinolaryngologic Diseases (1) · Otorhinolaryngologic Neoplasms (1) · Pathological Conditions, Signs and Symptoms (1)
Capecitabine (1) · tislelizumab (1)
Fujian Cancer Hospital (1) · Peking University People's Hospital (1)
China (2)